Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Haruma

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Alimentary Pharmacology & Therapeutics|December 4, 2004
Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in JapanK Haruma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 2, 1998
[Gastritis due to Helicobacter pylori]K Haruma
Internal Medicine (Tokyo, Japan)|May 25, 1999
Helicobacter heilmannii: a spiral shaped organism other than Helicobacter pyloriK Haruma
Gastroenterology Clinics of North America|October 13, 2000
Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer in JapanK Haruma
Internal Medicine (Tokyo, Japan)|June 9, 1998
Cytokines and immunomodulatory therapy in inflammatory bowel diseaseK Haruma
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 1998
[Epidemiology of gastrointestinal hemorrhage]M Yoshihara, K Haruma
Alimentary Pharmacology & Therapeutics|August 20, 2003
Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipideK Haruma, M Ito
Gut|August 1, 1994
Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disordersK Haruma, J A Wiste, M Camilleri
Alimentary Pharmacology & Therapeutics|February 6, 2010
Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection--the results of a multicentre, double-blind, randomized clinical trial (IMPACT study)H Hiraishi, K Haruma, H Miwa, et al.
Gut|August 1, 1992
Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcerS Wagner, U Gladziwa, K Haruma, et al.
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Alimentary Pharmacology & Therapeutics|December 4, 2004
Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in JapanK Haruma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 2, 1998
[Gastritis due to Helicobacter pylori]K Haruma
Internal Medicine (Tokyo, Japan)|May 25, 1999
Helicobacter heilmannii: a spiral shaped organism other than Helicobacter pyloriK Haruma
Gastroenterology Clinics of North America|October 13, 2000
Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer in JapanK Haruma
Internal Medicine (Tokyo, Japan)|June 9, 1998
Cytokines and immunomodulatory therapy in inflammatory bowel diseaseK Haruma
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 1998
[Epidemiology of gastrointestinal hemorrhage]M Yoshihara, K Haruma
Alimentary Pharmacology & Therapeutics|August 20, 2003
Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipideK Haruma, M Ito
Gut|August 1, 1994
Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disordersK Haruma, J A Wiste, M Camilleri
Alimentary Pharmacology & Therapeutics|February 6, 2010
Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection--the results of a multicentre, double-blind, randomized clinical trial (IMPACT study)H Hiraishi, K Haruma, H Miwa, et al.
Gut|August 1, 1992
Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcerS Wagner, U Gladziwa, K Haruma, et al.
Pageof 24